Cargando…
The National Clinical Care Commission Report to Congress: Summary and Next Steps
The U.S. is experiencing an epidemic of type 2 diabetes. Socioeconomically disadvantaged and certain racial and ethnic groups experience a disproportionate burden from diabetes and are subject to disparities in treatment and outcomes. The National Clinical Care Commission (NCCC) was charged with mak...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887605/ https://www.ncbi.nlm.nih.gov/pubmed/36701591 http://dx.doi.org/10.2337/dc22-0622 |
_version_ | 1784880376158617600 |
---|---|
author | Conlin, Paul R. Boltri, John M. Bullock, Ann Greenlee, M. Carol Lopata, Aaron M. Powell, Clydette Schillinger, Dean Tracer, Howard Herman, William H. |
author_facet | Conlin, Paul R. Boltri, John M. Bullock, Ann Greenlee, M. Carol Lopata, Aaron M. Powell, Clydette Schillinger, Dean Tracer, Howard Herman, William H. |
author_sort | Conlin, Paul R. |
collection | PubMed |
description | The U.S. is experiencing an epidemic of type 2 diabetes. Socioeconomically disadvantaged and certain racial and ethnic groups experience a disproportionate burden from diabetes and are subject to disparities in treatment and outcomes. The National Clinical Care Commission (NCCC) was charged with making recommendations to leverage federal policies and programs to more effectively prevent and control diabetes and its complications. The NCCC determined that diabetes cannot be addressed simply as a medical problem but must also be addressed as a societal problem requiring social, clinical, and public health policy solutions. As a result, the NCCC’s recommendations address policies and programs of both non–health-related and health-related federal agencies. The NCCC report, submitted to the U.S. Congress on 6 January 2022, makes 39 specific recommendations, including three foundational recommendations that non–health-related and health-related federal agencies coordinate their activities to better address diabetes, that all federal agencies and departments ensure that health equity is a guiding principle for their policies and programs that impact diabetes, and that all Americans have access to comprehensive and affordable health care. Specific recommendations are also made to improve general population-wide policies and programs that impact diabetes risk and control, to increase awareness and prevention efforts among those at high risk for type 2 diabetes, and to remove barriers to access to effective treatments for diabetes and its complications. Finally, the NCCC recommends that an Office of National Diabetes Policy be established to coordinate the activities of health-related and non–health-related federal agencies to address diabetes prevention and treatment. The NCCC urges Congress and the Secretary of Health and Human Services to implement these recommendations to protect the health and well-being of the more than 130 million Americans at risk for and living with diabetes. |
format | Online Article Text |
id | pubmed-9887605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-98876052023-02-08 The National Clinical Care Commission Report to Congress: Summary and Next Steps Conlin, Paul R. Boltri, John M. Bullock, Ann Greenlee, M. Carol Lopata, Aaron M. Powell, Clydette Schillinger, Dean Tracer, Howard Herman, William H. Diabetes Care The National Clinical Care Commission Report to Congress The U.S. is experiencing an epidemic of type 2 diabetes. Socioeconomically disadvantaged and certain racial and ethnic groups experience a disproportionate burden from diabetes and are subject to disparities in treatment and outcomes. The National Clinical Care Commission (NCCC) was charged with making recommendations to leverage federal policies and programs to more effectively prevent and control diabetes and its complications. The NCCC determined that diabetes cannot be addressed simply as a medical problem but must also be addressed as a societal problem requiring social, clinical, and public health policy solutions. As a result, the NCCC’s recommendations address policies and programs of both non–health-related and health-related federal agencies. The NCCC report, submitted to the U.S. Congress on 6 January 2022, makes 39 specific recommendations, including three foundational recommendations that non–health-related and health-related federal agencies coordinate their activities to better address diabetes, that all federal agencies and departments ensure that health equity is a guiding principle for their policies and programs that impact diabetes, and that all Americans have access to comprehensive and affordable health care. Specific recommendations are also made to improve general population-wide policies and programs that impact diabetes risk and control, to increase awareness and prevention efforts among those at high risk for type 2 diabetes, and to remove barriers to access to effective treatments for diabetes and its complications. Finally, the NCCC recommends that an Office of National Diabetes Policy be established to coordinate the activities of health-related and non–health-related federal agencies to address diabetes prevention and treatment. The NCCC urges Congress and the Secretary of Health and Human Services to implement these recommendations to protect the health and well-being of the more than 130 million Americans at risk for and living with diabetes. American Diabetes Association 2023-02 2023-01-26 /pmc/articles/PMC9887605/ /pubmed/36701591 http://dx.doi.org/10.2337/dc22-0622 Text en © 2023 by the American Diabetes Association https://www.diabetesjournals.org/journals/pages/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. |
spellingShingle | The National Clinical Care Commission Report to Congress Conlin, Paul R. Boltri, John M. Bullock, Ann Greenlee, M. Carol Lopata, Aaron M. Powell, Clydette Schillinger, Dean Tracer, Howard Herman, William H. The National Clinical Care Commission Report to Congress: Summary and Next Steps |
title | The National Clinical Care Commission Report to Congress: Summary and Next Steps |
title_full | The National Clinical Care Commission Report to Congress: Summary and Next Steps |
title_fullStr | The National Clinical Care Commission Report to Congress: Summary and Next Steps |
title_full_unstemmed | The National Clinical Care Commission Report to Congress: Summary and Next Steps |
title_short | The National Clinical Care Commission Report to Congress: Summary and Next Steps |
title_sort | national clinical care commission report to congress: summary and next steps |
topic | The National Clinical Care Commission Report to Congress |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887605/ https://www.ncbi.nlm.nih.gov/pubmed/36701591 http://dx.doi.org/10.2337/dc22-0622 |
work_keys_str_mv | AT conlinpaulr thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT boltrijohnm thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT bullockann thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT greenleemcarol thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT lopataaaronm thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT powellclydette thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT schillingerdean thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT tracerhoward thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT hermanwilliamh thenationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT conlinpaulr nationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT boltrijohnm nationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT bullockann nationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT greenleemcarol nationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT lopataaaronm nationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT powellclydette nationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT schillingerdean nationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT tracerhoward nationalclinicalcarecommissionreporttocongresssummaryandnextsteps AT hermanwilliamh nationalclinicalcarecommissionreporttocongresssummaryandnextsteps |